Indomethacin NDC 70710-1852

NDC codes

FDA NDC Directory

Product NDC (as listed)70710-1852Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70710-1852Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70710-1852-7	70710185207	5 BLISTER PACK in 1 CARTON (70710-1852-7) / 6 SUPPOSITORY in 1 BLISTER PACK (70710-1852-6)Marketed from Aug 3, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Indomethacin
Generic name (nonproprietary): indomethacin
Active ingredients: Indomethacin — 50 mg/1
Dosage form: Suppository
Route: Rectal
Labeler: Zydus Pharmaceuticals USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216184
Marketing start: Aug 3, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 70710-1852_796d8f36-e2ba-4f03-8e37-28590adfaed0SPL ID 796d8f36-e2ba-4f03-8e37-28590adfaed0SPL set ID 595e2f3e-c6d4-4a17-bc06-46512b4275b5RxCUI 197819UNII XXE1CET956
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N470710185207 followed by a unit qualifier and the quantity

Package 70710-1852-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 7, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Indomethacin suppository is indicated for: Moderate to severe rheumatoid arthritis including acute flares of chronic disease Moderate to severe ankylosing spondylitis Moderate to severe osteoarthritis Acute painful shoulder (bursitis and/or tendinitis) Acute gouty arthritis Indomethacin is a nonsteroidal anti-inflammatory drug indicated for: Moderate to severe rheumatoid arthritis including acute flares of chronic disease Moderate to severe ankylosing spondylitis Moderate to severe osteoarthritis Acute painful shoulder (bursitis and/or tendinitis) Acute gouty arthritis ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216184

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216184
Product	Strength	Form · route	Labeler	Product NDC
Indomethacin	Indomethacin 50 mg/1	SuppositoryRectal	Zydus Pharmaceuticals USA Inc.	70710-1958
Indomethacin	Indomethacin 50 mg/1	SuppositoryRectal	Zydus Lifesciences Limited	70771-1766